AAAAAA
Results:
1-15
|
Results: 15
Authors:
Breathnach, OS
Freidlin, B
Conley, B
Green, MR
Johnson, DH
Gandara, DR
O'Connell, M
Shepherd, FA
Johnson, BE
Citation: Os. Breathnach et al., Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: Sobering results, J CL ONCOL, 19(6), 2001, pp. 1734-1742
Authors:
Gastwirth, JL
Freidlin, B
Citation: Jl. Gastwirth et B. Freidlin, Freidlin, B., and Gastwirth, J. L. (2000), "should the median test be retired from general use?" The American Statistician 54, 161-164: Comment by Gartside and reply - Reply, AM STATISTN, 55(2), 2001, pp. 171-171
Authors:
Freidlin, B
Gastwirth, JL
Citation: B. Freidlin et Jl. Gastwirth, Changepoint tests designed for the analysis of hiring data arising in employment discrimination cases, J BUS ECON, 18(3), 2000, pp. 315-322
Authors:
Smith, MA
Freidlin, B
Ries, LAG
Simon, R
Citation: Ma. Smith et al., Increased incidence rates but no space-time clustering of childhood astrocytoma in Sweden, 1973-1992 - A population-based study of pediatric brain tumors, CANCER, 88(6), 2000, pp. 1492-1493
Authors:
Gastwirth, JL
Freidlin, B
Citation: Jl. Gastwirth et B. Freidlin, On power and efficiency robust linkage tests for affected sibs, ANN HUM GEN, 64, 2000, pp. 443-453
Authors:
Freidlin, B
Gastwirth, JL
Citation: B. Freidlin et Jl. Gastwirth, Should the median test be retired from general use?, AM STATISTN, 54(3), 2000, pp. 161-164
Authors:
Gastwirth, JL
Freidlin, B
Miao, WW
Citation: Jl. Gastwirth et al., The Shonubi case as an example of the legal system's failure to appreciatestatistical evidence, STAT SOC SC, 2000, pp. 405-413
Authors:
Smith, MA
Freidlin, B
Ries, LAG
Simon, R
Citation: Ma. Smith et al., Trends in reported incidence of primary malignant brain tumors in childrenin the United States - Response, J NAT CANC, 91(7), 1999, pp. 649-649
Authors:
Smith, MA
Freidlin, B
Ries, LAG
Simon, R
Citation: Ma. Smith et al., Trends in reported incidence of primary malignant brain tumors in childrenin the United States - Response, J NAT CANC, 91(11), 1999, pp. 973-974
Authors:
Cheson, BD
Vena, DA
Barrett, J
Freidlin, B
Citation: Bd. Cheson et al., Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias, J CL ONCOL, 17(8), 1999, pp. 2454-2460
Authors:
Smith, MA
Rubinstein, L
Anderson, JR
Arthur, D
Catalano, PJ
Freidlin, B
Heyn, R
Khayat, A
Krailo, M
Land, VJ
Miser, J
Shuster, J
Vena, D
Citation: Ma. Smith et al., Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins, J CL ONCOL, 17(2), 1999, pp. 569-577
Authors:
Bubley, GJ
Carducci, M
Dahut, W
Dawson, N
Daliani, D
Eisenberger, M
Figg, WD
Freidlin, B
Halabi, S
Hudes, G
Hussain, M
Kaplan, R
Myers, C
Oh, W
Petrylak, DP
Reed, E
Roth, B
Sartor, O
Scher, H
Simons, J
Sinibaldi, V
Small, EJ
Smith, MR
Trump, DL
Vollmer, R
Wilding, G
Citation: Gj. Bubley et al., Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: Recommendations from the prostate-specific antigen working group, J CL ONCOL, 17(11), 1999, pp. 3461-3467
Authors:
Freidlin, B
Korn, EL
George, SL
Citation: B. Freidlin et al., Data monitoring committees and interim monitoring guidelines, CONTR CL TR, 20(5), 1999, pp. 395-407
Authors:
Freidlin, B
Podgor, MJ
Gastwirth, JL
Citation: B. Freidlin et al., Efficiency robust tests for survival or ordered categorical data, BIOMETRICS, 55(3), 1999, pp. 883-886
Authors:
Freidlin, B
Gastwirth, JL
Citation: B. Freidlin et Jl. Gastwirth, Unconditional versions of several tests commonly used in the analysis of contingency tables, BIOMETRICS, 55(1), 1999, pp. 264-267
Risultati:
1-15
|